skip to Main Content
Chairman and Co-founder of AIM-HI Portfolio Company Tvardi Cited in CNN Article

Chairman and Co-founder of AIM-HI Portfolio Company Tvardi Cited in CNN Article

While a longer recovery course might be expected for someone such as Herbert who faced a more severe illness, there’s also concern for more permanent lung damage, according to Dr. Ronald DePinho, professor and past president of MD Anderson Cancer Center and co-founder of Tvardi Therapeutics. DePinho is particularly worried that the immune response to Covid-19 may cause irreversible scarring known as pulmonary fibrosis.

Read more: https://www.cnn.com/2020/05/19/health/coronavirus-recovery-long-journey-wellness/index.html

Back To Top